Arrowhead Pharmaceuticals Inc. buy Piper Sandler
Start price
13.01.26
/
50%
€58.38
Target price
13.01.27
€94.35
Performance (%)
-3.56%
Price
13.01.26
€56.30
Summary
This prediction is currently active. With a performance of -3.56%, the BUY prediction for Arrowhead Pharmaceuticals Inc. by Piper_Sandler is down slightly. This prediction currently runs until 13.01.27. The prediction end date can be changed by Piper_Sandler at any time. Piper_Sandler has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Arrowhead Pharmaceuticals Inc. | -3.56% |
| iShares Core DAX® | 1.644% |
| iShares Nasdaq 100 | 0.747% |
| iShares Nikkei 225® | 2.442% |
| iShares S&P 500 | 0.618% |
Comments by Piper_Sandler for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals (NASDAQ:ARWR) had its "overweight" rating reaffirmed by analysts at Piper Sandler. They now have a $110.00 price target on the stock, up previously from $100.00.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by Piper_Sandler for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€55.98
17.12.25
17.12.25
€85.13
17.12.26
17.12.26
0.57%
13.01.26
13.01.26
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€34.14
19.11.25
19.11.25
€60.47
19.11.26
19.11.26
64.91%
13.01.26
13.01.26
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€25.00
27.11.24
27.11.24
€42.54
27.11.25
27.11.25
100.00%
28.11.25
28.11.25
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€16.42
08.10.24
08.10.24
€56.53
08.10.25
08.10.25
91.78%
09.10.25
09.10.25

